Corcept Therapeutics Incorporated (CORT) — Cash Flow-to-Debt Ratio
Corcept Therapeutics Incorporated (CORT) has a Cash Flow-to-Debt Ratio of -0.09x as of March 2026, meaning its operating cash flow of $-16.77 Million could theoretically repay 0% of its total liabilities ($176.89 Million) in one year. See how financially flexible is Corcept Therapeutics Incorporated to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Corcept Therapeutics Incorporated Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Corcept Therapeutics Incorporated across 23 annual periods. For the full cash flow conversion analysis, see Corcept Therapeutics Incorporated cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Corcept Therapeutics Incorporated (2003–2025)
Year-by-year debt coverage analysis for Corcept Therapeutics Incorporated. Check CORT cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.75x | $142.00 Million | $188.85 Million | ▼ -38.9% |
| 2024 | 1.23x | $198.07 Million | $160.96 Million | ▲ +11.2% |
| 2023 | 1.11x | $127.04 Million | $114.81 Million | ▼ -25.0% |
| 2022 | 1.47x | $120.32 Million | $81.59 Million | ▼ -57.9% |
| 2021 | 3.50x | $167.89 Million | $47.95 Million | ▲ +11.5% |
| 2020 | 3.14x | $151.97 Million | $48.39 Million | ▼ -5.1% |
| 2019 | 3.31x | $136.12 Million | $41.13 Million | ▲ +2.5% |
| 2018 | 3.23x | $115.67 Million | $35.81 Million | ▲ +56.7% |
| 2017 | 2.06x | $60.94 Million | $29.57 Million | ▲ +206.7% |
| 2016 | 0.67x | $18.39 Million | $27.37 Million | ▲ +617.8% |
| 2015 | 0.09x | $3.13 Million | $33.44 Million | ▲ +113.0% |
| 2014 | -0.72x | $-27.38 Million | $38.02 Million | ▲ +18.3% |
| 2013 | -0.88x | $-37.06 Million | $42.06 Million | ▲ +8.5% |
| 2012 | -0.96x | $-36.02 Million | $37.39 Million | ▲ +82.3% |
| 2011 | -5.45x | $-27.40 Million | $5.03 Million | ▲ +5.6% |
| 2010 | -5.77x | $-22.29 Million | $3.86 Million | ▲ +22.3% |
| 2009 | -7.43x | $-17.97 Million | $2.42 Million | ▼ -16.0% |
| 2008 | -6.40x | $-18.36 Million | $2.87 Million | ▼ -75.8% |
| 2007 | -3.64x | $-10.96 Million | $3.01 Million | ▲ +44.5% |
| 2006 | -6.56x | $-23.24 Million | $3.54 Million | ▼ -35.6% |
| 2005 | -4.84x | $-17.23 Million | $3.56 Million | ▲ +35.7% |
| 2004 | -7.52x | $-13.72 Million | $1.82 Million | ▼ -15.6% |
| 2003 | -6.51x | $-10.00 Million | $1.54 Million | — |